Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome

A. Gomez-Pan, M. F. Scanlon, M. O. Thorner, L. H. Rees, Andrew V Schally, R. Hall, G. M. Besser

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Growth hormone (GH) secretion has been studied in two patients with the carcinoid syndrome during glucose loading and growth hormone-release inhibiting hormone (GHRIH), somatostatin) infusion. Both patients had elevated fasting GH levels which were not suppressed by glucose; GH levels fell rapidly during GHRIH infusion. One patient also had hyperprolactinaemia with galactorrhoea and the prolactin (PRL) levels were unaltered by GHRIH. The association between carcinoid tumours and abnormalities of GH and PRL secretion is discussed.

Original languageEnglish
Pages (from-to)575-581
Number of pages7
JournalClinical Endocrinology
Volume10
Issue number6
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Carcinoid Tumor
Somatostatin
Prolactin
Growth Hormone
Hormones
Glucose
Fasting

ASJC Scopus subject areas

  • Endocrinology

Cite this

Gomez-Pan, A., Scanlon, M. F., Thorner, M. O., Rees, L. H., Schally, A. V., Hall, R., & Besser, G. M. (1979). Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome. Clinical Endocrinology, 10(6), 575-581.

Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome. / Gomez-Pan, A.; Scanlon, M. F.; Thorner, M. O.; Rees, L. H.; Schally, Andrew V; Hall, R.; Besser, G. M.

In: Clinical Endocrinology, Vol. 10, No. 6, 01.12.1979, p. 575-581.

Research output: Contribution to journalArticle

Gomez-Pan, A, Scanlon, MF, Thorner, MO, Rees, LH, Schally, AV, Hall, R & Besser, GM 1979, 'Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome', Clinical Endocrinology, vol. 10, no. 6, pp. 575-581.
Gomez-Pan, A. ; Scanlon, M. F. ; Thorner, M. O. ; Rees, L. H. ; Schally, Andrew V ; Hall, R. ; Besser, G. M. / Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome. In: Clinical Endocrinology. 1979 ; Vol. 10, No. 6. pp. 575-581.
@article{24f698ab2a18472fa4ebdfa2e73ed113,
title = "Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome",
abstract = "Growth hormone (GH) secretion has been studied in two patients with the carcinoid syndrome during glucose loading and growth hormone-release inhibiting hormone (GHRIH), somatostatin) infusion. Both patients had elevated fasting GH levels which were not suppressed by glucose; GH levels fell rapidly during GHRIH infusion. One patient also had hyperprolactinaemia with galactorrhoea and the prolactin (PRL) levels were unaltered by GHRIH. The association between carcinoid tumours and abnormalities of GH and PRL secretion is discussed.",
author = "A. Gomez-Pan and Scanlon, {M. F.} and Thorner, {M. O.} and Rees, {L. H.} and Schally, {Andrew V} and R. Hall and Besser, {G. M.}",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "10",
pages = "575--581",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome

AU - Gomez-Pan, A.

AU - Scanlon, M. F.

AU - Thorner, M. O.

AU - Rees, L. H.

AU - Schally, Andrew V

AU - Hall, R.

AU - Besser, G. M.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - Growth hormone (GH) secretion has been studied in two patients with the carcinoid syndrome during glucose loading and growth hormone-release inhibiting hormone (GHRIH), somatostatin) infusion. Both patients had elevated fasting GH levels which were not suppressed by glucose; GH levels fell rapidly during GHRIH infusion. One patient also had hyperprolactinaemia with galactorrhoea and the prolactin (PRL) levels were unaltered by GHRIH. The association between carcinoid tumours and abnormalities of GH and PRL secretion is discussed.

AB - Growth hormone (GH) secretion has been studied in two patients with the carcinoid syndrome during glucose loading and growth hormone-release inhibiting hormone (GHRIH), somatostatin) infusion. Both patients had elevated fasting GH levels which were not suppressed by glucose; GH levels fell rapidly during GHRIH infusion. One patient also had hyperprolactinaemia with galactorrhoea and the prolactin (PRL) levels were unaltered by GHRIH. The association between carcinoid tumours and abnormalities of GH and PRL secretion is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0018575060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018575060&partnerID=8YFLogxK

M3 - Article

C2 - 476984

AN - SCOPUS:0018575060

VL - 10

SP - 575

EP - 581

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 6

ER -